- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Materials and Methods材料和方法http://www.medscape.com/viewarticle/736821_2
Results结果http://www.medscape.com/viewarticle/736821_3
Discussion
Virus-specific T-cell responses have been described in seronegative partners after sexual contact with HIV-infected individuals (5/5 with homosexual intercourse, 3/6 with heterosexual intercourse), in occupationally HCV-exposed (n = 5/10) or in HIV- exposed (n = 6/8) health care workers and in seronegative intravenous drug abusers (46–58% of cases).[8–14] We hypothesized that virus-specific T-cell responses may be even more frequent in seronegative sexual partners of patients with chronic hepatitis B because HBV is considered to be much more infectious than HCV and HIV with high risk of transmission in the absence of HBV-specific humoral immunity, i.e. after missing or ineffective HBV vaccination. All tested sexual partners were negative for HBsAg, anti-HBs or anti-HBc in serum.
HBV-DNA was measured with a highly sensitive PCR assay and could not be detected either in serum or in PBMC in all individuals. However, HBV-specific T-cell responses and virus-induced TH1 cytokine secretion indicated past, but controlled viral replication.
It may be speculated that the healthy sexual partners have either undergone subclinical, but completely resolved HBV infection in the past with resulting long-lasting T-cell memory possibly preventing re-infection or that these individuals harbour seronegative occult HBV replication which continuously stimulates the cellular immune system, but which is also controlled by T-cell immunity.
Seronegative occult HBV infection is defined by presence of HBV-DNA in the liver or in PBMC in the absence of HBsAg, anti-HBc and anti-HBs in serum.[18,19] However, we could not investigate hepatic tissue for HBV-DNA replication, because it was unethical to perform liver biopsies in individuals without hepatic disease.
The single measurement of HBV-DNA in serum and in PBMC at study entry may not exclude minimal levels of replicating virus, because fluctuating HBV-DNA levels can be observed both in serum and in PBMC with repetitive experiments after resolution of acute HBV infection.[20–22] However, even during clinical follow-up, no evidence of hepatitis could be detected in the exposed sexual partners assuming that active relevant infection had not occurred.
Analysis of the proliferation assay revealed multispecific T-cell responses in five of six investigated individuals. They were directed against different HBV epitopes with a predominance of HBV core antigen-specific sequences. Recent data in occult HBV infection could detect virus-specific T-cell expansion only in anti-HBc positive patients, but not in seronegative cases.[23] The Italian individuals were all infected with chronic hepatitis C, which leads the authors to the idea, that control of HBV replication in occult seronegative HBV infection was either mainly facilitated by the innate immune system or by the interference of hepatitis C viral proteins with the hepatitis B virus. Our results indicate the presence of an HBV-specific adaptive immune response in seronegative individuals, especially because virus-specific T-cell responses or cytokine secretion could not be observed in negative controls. Moreover, the observation that proliferative responses increased after vaccination indicates that the cellular immune system of the healthy sexual partners has a memory function with cross-reactivity between different epitopes, because both core and pre-S responses emerged, even though these epitopes are absent in the vaccines used. Epitope spreading with increasing CD8+ T-cell responses has been observed i.e. in mice after single-epitope DNA vaccination against LCMV infection.[24]Thus, it may be speculated that the underlying chronic hepatitis C infection may have impaired the cellular immune response in the Italian study. However, this theory does not exclude the possibility that the innate immune system is of crucial relevance in the control of subclinical HBV infection in both study cohorts.
The observed proliferative responses were mostly weak and fluctuating between different time points. The strength of the cellular immunity resembles previous results of our group in hepatitis C patients who cleared low levels of HCV viremia in the absence of a strong adaptive immune response which might be an explanation for low rates of HCV seroconversion after occupational exposure.[25] The quality of proliferative responses can be compared to observations after resolution of acute HBV infection.[20,21,26–28] The HBV core-protein harbours the most frequently recognized epitopes both in our patients, in self-limited acute and in occult HBV infection.[21,23,27,28] Thus, HBV core directed T cells may be most important for the successful prevention of clinical symptoms in the investigated healthy seronegative sexual partners.
Although we could not perform FACS-analysis in the present patient cohort, it is tempting to speculate that their HBV-specific CD4+ T cells act as effector memory cells. The secreted cytokines showed a TH1-profile with a dominant IFNγ secretion. IFNγ is one of the most important cytokines of the antiviral immune response in acute HBV infection[29,30] and is critically involved in HBV clearance by noncytolytic viral eradication.[31,32] Interestingly, Penna et al. [21] observed a TH1 cytokine profile with IFNγ production in the acute phase of HBV infections, whereas in the recovery phase the cytokine pattern switched to a TH0-profile with detection of IFNγ, IL-4 and IL-5. In our experiments, we could only measure IL-10 as member of the TH2 cytokine family, which, however, was undetectable in all seronegative sexual partners. Thus, the status of our investigated individuals may not just be a single acute HBV infection, but the result of repetitive exposure leading to subclinical infections caused by ongoing unprotected sexual intercourse with chronically HBV infected patients.
Our study is limited by several restrictions: (i) The number of studied individuals is small, (ii) a thorough characterization of HBV-specific T- cell responses with FACS analysis or intracellular cytokine staining could not be performed in this pilot project, (iii) the use of overlapping peptides may facilitate stimulation not only of HBV-specific CD4+, but also of CD8+ T cells in the proliferation assay which does not allow differentiation of both cell types without the mentioned additional immunological techniques, (iv) the observed HBV-specific cellular immune responses were weak and fluctuating, however, positive reactions of control antigen and absence of virus-specific reactions in the healthy control group indicate HBV-induced T-cell immunity.
In conclusion, our investigations provide the first basic evidence that HBV-specific T-cell responses can be observed in healthy seronegative sexual partners of patients with chronic HBV infection. It is tempting to further specify these results in the future, because the cellular immune system may prevent acute HBV episodes after unprotected sexual intercourse in the absence of humoral immunity. However, because the antiviral efficacy of the HBV-specific T-cells is not finally proven, vaccination of exposed individuals and use of condoms must stay the standard of care to reliably prevent transmission of the disease.
|
|